Brandywine Global Investment Management LLC cut its stake in Davita Inc (NYSE:DVA) by 22.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 175,943 shares of the company’s stock after selling 51,331 shares during the quarter. Brandywine Global Investment Management LLC’s holdings in Davita were worth $12,712,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently modified their holdings of the company. Nomura Asset Management Co. Ltd. raised its stake in shares of Davita by 8.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 24,240 shares of the company’s stock worth $1,751,000 after purchasing an additional 1,860 shares during the last quarter. Rock Springs Capital Management LP purchased a new stake in shares of Davita in the fourth quarter worth approximately $5,787,000. BlueCrest Capital Management Ltd purchased a new stake in shares of Davita in the fourth quarter worth approximately $2,213,000. Amundi Pioneer Asset Management Inc. purchased a new stake in shares of Davita in the fourth quarter worth approximately $7,290,000. Finally, AXA purchased a new stake in shares of Davita in the fourth quarter worth approximately $932,000. 85.83% of the stock is owned by hedge funds and other institutional investors.
In other Davita news, insider James K. Hilger sold 3,572 shares of the stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $78.95, for a total transaction of $282,009.40. Following the completion of the transaction, the insider now directly owns 33,649 shares of the company’s stock, valued at $2,656,588.55. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 2.00% of the company’s stock.
Davita Inc (NYSE:DVA) opened at $72.26 on Tuesday. The stock has a market capitalization of $13,187.72, a P/E ratio of 21.01, a PEG ratio of 1.39 and a beta of 1.03. The company has a quick ratio of 2.82, a current ratio of 2.88 and a debt-to-equity ratio of 1.87. Davita Inc has a twelve month low of $52.51 and a twelve month high of $80.71.
Davita (NYSE:DVA) last released its earnings results on Tuesday, February 13th. The company reported $0.92 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.94 by ($0.02). The business had revenue of $2.78 billion during the quarter, compared to the consensus estimate of $3.90 billion. Davita had a net margin of 4.65% and a return on equity of 12.86%. During the same period in the prior year, the company earned $0.98 earnings per share. analysts anticipate that Davita Inc will post 4.15 EPS for the current year.
TRADEMARK VIOLATION WARNING: This story was posted by Markets Daily and is owned by of Markets Daily. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.themarketsdaily.com/2018/03/13/brandywine-global-investment-management-llc-has-12-71-million-stake-in-davita-inc-dva.html.
Davita Company Profile
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.